Epidemiology of ADHD

Author/s
Luis A. Rohde, Rachel E. Verin, Guilherme V. Polanczyk
Citation
Issue 2 Spring 2012
CEPiP.2012.1.6-9
Abstract

In this selective review of the literature, we present recent data on the epidemiology of Attention Deficit Hyperactivity Disorder (ADHD) across the life-cycle. The worldwide ADHD prevalence rates are around 5.3% in children and adolescents and 2.5% in adults. The literature suggests that 40 – 60% of affected children continue having the disorder during adulthood, depending on the criteria for persistence applied. Demographic correlates such as gender, socio-economic stratum and ethnicity impact on prevalence rates in the community. There are clear barriers for treatment access even in developed countries.

Keywords: ADHD, hyperkinetic disorder, prevalence, epidemiology

Cite as: Cutting Edge Psychiatry in Practice 2012, 2(1):6-9; https://doi.org/10.65031/hwat7461

References

  1. Kieling R, Rohde LA. ADHD in children and adults: Diagnosis and Prognosis. Curr Top Behav Neurosci 2011 Apr 16.              
  2. World Health Organization. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva: WHO; 1993.  
  3. American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders (4th edition, Text Revision) (DSM-IV-TR). Washington, DC: American Psychiatric Association. https://doi.org/10.1176/appi.books.9780890423349 https://doi.org/10.1176/appi.books.9780890423349
  4. Rohde LA. Is there a need to reformulate ADHD criteria in future classification systems? Child Adolesc Psychiatric Clin N Am 2008; 17(2):405-20. 
  5. Polanczyk G, Rohde L A. Epidemiology of Attention-Deficit / Hyperactivity Disorder across the lifespan. Curr Opin Psychiatry 2007;20(4):386-92. https://doi.org/10.1097/yco.0b013e3281568d7a
  6. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The Worldwide Prevalence of ADHD: A Systematic Review and Meta-regression Analysis. Am J Psychiatry 2007;164, 942-948. https://doi.org/10.1176/ajp.2007.164.6.942
  7. Merikangas KR, He JP, Brody D, Fisher PW, Bourdon K, Koretz DS. Prevalence and Treatment of Mental Disorders Among US Children in the 2001 -2004 NHANES. Pediatrics 2010;125;75-81. https://doi.org/10.1542/peds.2008-2598
  8. Merikangas KR, He JP, Burstein M, Swanson SA, Avenevoli S, Cui L, Benjet C, Georgiades K, Swendsen J. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication - Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 2010;49 (10):980-9. https://doi.org/10.1016/j.jaac.2010.05.017
  9. Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, Lépine JP, Ormel J, Posada-Villa J, Zaslavsky AM, Jin R. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007;190, 402-409. https://doi.org/10.1192/bjp.bp.106.034389
  10. Simon V, Czobor P, Bálint S, Mészáros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 2009;194:204-211. https://doi.org/10.1192/bjp.bp.107.048827
  11. Bernardi S, Faraone SV, Cortese S, Kerridge S, Pallanti S, Wang S, Blanco C. The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychol Med 2011. https://doi.org/10.1017/s003329171100153x
  12. Faraone SV, Biederman J, Mick E: The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 2006, 36:159-65. https://doi.org/10.1017/s003329170500471x
  13. Larsson H, Dilshad R, Lichtenstein P, Barker ED. Developmental trajectories of DSM-IV symptoms of attention-deficit/ hyperactivity disorder: genetic effects, family risk and associated psychopathology. J Child Psychol Psychiatry. 2011;52(9):954-63. https://doi.org/10.1111/j.1469-7610.2011.02379.x
  14. Weiss G, Hechtman L, Milroy T, Perlman T: Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Adolesc Psychiatry 1985; 24: 211-220. https://doi.org/10.1016/s0002-7138(09)60450-7
  15. Kessler RC, Adler LA, Barkley R et al.: Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry 2005, 57:1442-51. https://doi.org/10.1016/j.biopsych.2005.04.001
  16. Miller TW, Nigg JT, Miller RL Attention deficit hyperactivity disorder in African American children: what can be concluded from the past ten years? Clin Psychol Rev. 2009;29(1):77-86. https://doi.org/10.1016/j.cpr.2008.10.001
  17. Singh I. Beyond polemics: science and ethics of ADHD. Nature Rev 2008; 9: 957-964. https://doi.org/10.1038/nrn2514
  18. Polanczyk G, Rohde LA, Szobot C, Schmitz M, Montiel-Nava C, Bauermeister JJ. Treatment of ADHD in Latin America and the Caribbean. J Am Acad Child Adol Psychiatry 2008; 47(6):721-722. https://doi.org/10.1097/chi.0b013e31816c0008
  19. Sayal K, Ford T, Goodman R. Trends in recognition of and service use for attention-deficit hyperactivity disorder in Britain, 1999-2004. Psychiatr Serv 2010;61(8):803-10. https://doi.org/10.1176/ps.2010.61.8.803